Advantages of laparoscopic cholecystectomy (LC) for most of patients have been extensively recognized, and (LC) has become the golden standard in treating benign gallbladder diseases. When LC began in early 90's pregnancy, previous abdominal surgery, obesity, cirrhosis, and acute cholecystitis were considered absolute contraindications for the laparoscopic skills and instrumentation, a range of increasingly complex procedures has been performed, making all of these traditional contraindications at best relative. Several studies reported good results and suggested liberal use of LC in patients with early-stage cirrhosis and symptomatic gallstone disease. However, its benefits and successful use in patients with cirrhotic portal hypertension (CPH) are not well-documented. Based on our previous studies on the influence of LC on hepatic function and our experience with LC for cirrhotic patients, LC has been successfully performed for patients with Cirrhotic Portal Hypertension. New studies reports safety of LC in cirrhotic patients class Child's A-B patients.
Aim of the work
Study aims to evaluate Laparoscopic cholecystectomy in patients with cirrhotic portal hypertension regarding the intra-operative difficulties and short-term post-operative outcomes including: bleeding, bile leakage, wound infection and hepatic insufficiency